On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Julio Rosenstock

ResearcherPublications, citations & collaboration network

Julio Rosenstock is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Julio Rosenstock have?

ScholarIQindexed works

Julio Rosenstock has 691 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Julio Rosenstock have?

ScholarIQcitation count

Julio Rosenstock has 68,054 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Julio Rosenstock?

ScholarIQh-index

Julio Rosenstock has an h-index of 120 in OpenAlex.

What is the i10-index of Julio Rosenstock?

ScholarIQi10-index

Julio Rosenstock has an i10-index of 327 in OpenAlex.

What is the ORCID of Julio Rosenstock?

ScholarIQorcid

The ORCID for Julio Rosenstock is on the source record.

What is the OpenAlex record for Julio Rosenstock?

ScholarIQopenalex

The OpenAlex for Julio Rosenstock is on the source record.

What are the most-cited papers on Julio Rosenstock?

ScholarIQmost cited works
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso, Stephen C. Bain, Agostino Consoli, Freddy G. Eliaschewitz, Esteban Jódar, Lawrence A. Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark Warren, Vincent Woo, Oluf H. Hansen, Anders G. Holst, Jonas Pettersson, Tina Vilsbøll
New England Journal of Medicine. 20166,751 CitationsOPEN ACCESS
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John Wilding, Rachel L. Batterham, Salvatore Calanna, Melanie J. Davies, Luc F. Van Gaal, Ildiko Lingvay, Barbara McGowan, Julio Rosenstock, Marie Thi Dao Tran, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F. Kushner
New England Journal of Medicine. 20214,748 CitationsOPEN ACCESS
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais, Jeffrey L. Probstfield, Jeffrey S. Riesmeyer, Matthew C. Riddle, Lars Rydén, Denis Xavier, Charles Atisso, Leanne Dyal, Stephanie Hall, Rao Ps, G.C. Wong, Álvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C. Cushman, Edward Franek, Nicolae Hâncu, M Hanefeld, Shaun Holt, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev, Mercedes Abella, Andrea Alebuena, Sandra Almagro, Eduardo Amoroso, Paula Anadon, Elizabeth Andreu, Guillermo Aristimuño, Maria Arzadun, María Antonietta Barbieri, Raúl Barcudi, Ines Bartolacci, Gabriel Bolobanich, Anselmo P. Bordonava, Miguel Bustamante Labarta, B. Bustos, Alberto Caccavo, Alejandra Camino, María del Rocío Cantero, Maria Carignano, Luis R Cartasegna, Marcela Cipullo, Víctor Commendatore, Victoria Conosciuto, Osvaldo Costamagna, Claudia A. Crespo, Jose Cuello, Carlos Alberto Cuneo, Sandra Cusimano, Sofia Dean, Claudio Fabián Dituro, Andrea Domínguez, Miguel Farah, Alberto Fernandez, Florencia Fernandez, Adriana Cristina Ferrari, Patricia Flammia, José Antonio Fuentealba, Karina Beatriz Gallardo, C. Perez Garcia, Ruben Garcia Duran, Marcelo Garrido, Rodolfo Gavícola, Claudio Gerbaudo, Graciela Gilli, Ana Paula Giotto, Pedro Godoy Bolzán, Oscar Gómez Vilamajó, Fernando Guerlloy, Cristian Guridi, Narcisa Gutierrez Garrido, Eduardo Hasbani, Sonia Hermida, Miguel Hominal, Adrian D. Hrabar, Adrián Ingaramo, Alejandra Izzicupo, Mario Krynski, Mariana Lagrutta, Paulina Virginia Lanchiotti, Maria Langhe, Veronica Leonard, Javier Llanos, Ricardo López Santi
The Lancet. 20193,109 CitationsOPEN ACCESS
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Juan P. Frías, Melanie J. Davies, Julio Rosenstock, Federico C. Pérez Manghi, Laura Fernández Landó, Brandon K. Bergman, Bing Liu, Xuewei Cui, Katelyn Brown
New England Journal of Medicine. 20211,951 CitationsOPEN ACCESS
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, Kelley R. Branch, Stefano Del Prato, Nardev S. Khurmi, Carolyn S.P. Lam, Renato D. Lópes, John J.V. McMurray, Richard E. Pratley, Julio Rosenstock, Hertzel C. Gerstein
The Lancet Diabetes & Endocrinology. 20211,549 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial